Measurement of insulin-like growth factor II by a specific radioreceptor assay in serum of normal individuals, patients with abnormal growth hormone secretion, and patients with tumor-associated hypoglycemia

The Journal of Clinical Endocrinology and Metabolism
W H DaughadayM Kapadia

Abstract

A radioreceptor assay for insulin-like growth factor II (IGF-II) is described in which [125I]IGF-II is bound by rat placental membranes. IGF-I and other insulin-related peptides have less than 1% of the potency of IGF-II in displacing [125I]-IGF-II. IGF-II is extracted from its serum binding protein with a simple acid-ethanol step. After neutralization with Tris base, the extract is introduced directly into the radioreceptor assay. Results are expressed in terms of a reference serum with an assigned potency of 1 U/ml. By this method, serum from normal adults, 20-69 yr of age, had a mean (+/-SE)IGF-II activity of 0.73 +/- 0.03; higher concentrations were noted in adults more than 70 years of age (1.05 +/- 0.05), in cord serum (1.55 +/- 0.24), and in short children with normal GH secretion (0.88 +/- 0.42). In hypopituitary dwarfism, serum IGF-II activity was reduced (0.50 +/- 0.05), but in acromegaly, it was not increased (0.77 +/- 0.06). In 10 of 14 serum samples from patients with tumor-related hypoglycemia, the IGF-II exceeded the normal 95.5% confidence limits. In 8 of these sera, IGF-I by RIA was low, and in 5, it was essentially unmeasurable. These results with a new radioreceptor assay for IGF-II provide additional evidenc...Continue Reading

Citations

Apr 18, 2008·Langenbeck's Archives of Surgery·F FamàO Saint Marc
Apr 1, 1986·Metabolism: Clinical and Experimental·T J Merimee
Jan 1, 1987·Domestic Animal Endocrinology·F C BuonomoD R Campion
Oct 1, 1988·Domestic Animal Endocrinology·F C BuonomoD R Campion
May 20, 2000·Psychoneuroendocrinology·A N EliasA F Wilson
Dec 10, 1981·The New England Journal of Medicine·P GordenJ Roth
May 13, 1982·The New England Journal of Medicine·E R FroeschU Widmer
Apr 9, 1992·The New England Journal of Medicine·K S Polonsky
Jan 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·P Rotwein
Sep 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·W H Daughaday, M Kapadia
Jun 1, 1997·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·A HöögU G Falkmer
May 1, 1990·The Journal of Clinical Investigation·E T ShapiroH S Tager
Jan 1, 1986·Mayo Clinic Proceedings·C F Abboud
Oct 15, 2010·Pathology, Research and Practice·Mutsushi MatsuyamaMakoto Kuroda
Oct 1, 1996·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·F A Frizelle, M V Pfiefer
Aug 1, 1985·General and Comparative Endocrinology·W H DaughadayI K Mariz
Feb 1, 1994·Diabetes Research and Clinical Practice·M S Lewitt
Jun 1, 1988·Diabetes/metabolism Reviews·M Press
Jun 1, 1986·Journal of the American Geriatrics Society·D RudmanI W Rudman
Mar 1, 1984·Clinics in Endocrinology and Metabolism·K Hall, V R Sara
Aug 3, 2006·The American Journal of Chinese Medicine·Md Rafiqul AlamNam Soo Kim
Sep 17, 1999·Revista do Hospital das Clínicas·C CukierH W Pinotti
Mar 1, 1984·Clinics in Endocrinology and Metabolism
Sep 1, 1993·Metabolism: Clinical and Experimental·L S Phillips, D G Robertson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.